Prevalence of neutralizing antibodies to dengue virus serotypes in university students from Tabasco, Mexico;Prevalencia de anticuerpos neutralizantes contra los serotipos del virus dengue en universitarios de Tabasco, México

Salud Publica de Mexico

Volumn 50, Issue 5, 2008, Pages 362-366

  Sánchez Burgos, Gilma Guadalupe ^a,b   López Alvarado, Miguel Ángel ^b   Castañeda Desales, Deyanira ^c   Ruiz Gómez, Juan ^c   Ramos Castañeda, José ^c  

^a DEPARTAMENTO DE FÍSICA APLICADA   (Mexico)

^b UNIVERSIDAD JUÁREZ AUTÓNOMA DE TABASCO   (Mexico)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Antibodies; Dengue; Mexico; Viral transmission

Indexed keywords

EID: 57349113870     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Kroeger A, Nathan M, Hombach J. Dengue. Nat Rev Microbiol 2004;2(5):360-361.
2. Ligon BL. Dengue fever and dengue hemorrhagic fever: a review of the history, transmission, treatment, and prevention. Semin Pediatr Infect Dis 2005;16(1):60-65.
3. Anderson KB. Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet 2007;369(9571):1452- 1459.
4. Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 2006;19(5):429-436.
5. Wearing HJ, Rohani P. Ecological and immunological determinants of dengue epidemics. Proc Natl Acad Sci USA 2006;103(31):11802-11807.
6. Halstead SB. Dengue in the Americas and Southeast Asia: do they differ? Rev Panam Salud Publica 2006;20(6):407-415.
7. Navarrete-Espinosa J.Prevalence of dengue and leptospira antibodies in the state of Veracruz, Mexico. Salud Publica Mex 2006;48(3):220-228.
8. Lorono-Pino MA, Farfan-Ale JA, Rosado-Paredes EP, Arjona-Torres AI, Flores-Flores LF, Manzano-Cabrera LA, et al. Prevalencia de anticuerpos contra el virus dengue en Yucatán, México, 1985. Rev Latinoam Microbiol 1989;31:259-262.
9. SINAVE. Dirección General de Epidemiología. Secretaría de Salud. [Consultado en septiembre de 2007]. Disponible en: http://www.dgepi.salud.gob.mx/sinave/index.htm.
10. Guzman MG. Neutralizing antibodies after infection with dengue 1 virus. Emerg Infect Dis 2007; 13(2):282-186.
11. Adams B. Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci USA 2006;103(38):14234-14239.
12. Guzman MG. Epidemiologic studies on Dengue in Santiago de Cuba, 1997. Am J Epidemiol 2000;152(9):793-799; discussion 804.